| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.08 | 0.3 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |